1st March, 2012
People with MS already using approved therapies can still contribute to clinical research. Trialling new therapies can help towards improved management of MS and clinical studies increase our understanding of the condition.
With ‘add-on’ clinical trials people may be given existing therapies and investigational therapies together. Epidemiological (population based) studies can reveal trends in prevalence and identify potential triggers. One such study currently recruiting in the Sydney metropolitan area is the MIDAS study, which will map the incidence, prevalence and clinical features of MS .
To find out more about clinical research and search for trials in your area visit www.mstrials.org.au
To view the articles in Next 26, please click on the link below
- Kiss Goodbye to MS 2012
- $3.7 million in grants
- Stepping up stem cell research for MS
- Movement in Falls
- Clinical Research (article above)
- Amazing Everyday People
- Where to direct the f5m+ funds?
To download a copy of the Next 26 newsletter please click here